ICON PLC
NASDAQ:ICLR

Watchlist Manager
ICON PLC Logo
ICON PLC
NASDAQ:ICLR
Watchlist
Price: 212.15 USD -2.13% Market Closed
Market Cap: 17.5B USD
Have any thoughts about
ICON PLC?
Write Note

Intrinsic Value

The intrinsic value of one ICLR stock under the Base Case scenario is 307.98 USD. Compared to the current market price of 212.15 USD, ICON PLC is Undervalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ICLR Intrinsic Value
307.98 USD
Undervaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ICON PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ICLR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ICLR?
Bearish
Neutral
Bullish

Fundamental Analysis

ICON PLC
IE
Life Sciences Tools & Services
Market Cap
17.5B USD
IPO
May 15, 1998
Employees
38 330
Ireland
Market Cap
17.5B USD
Industry
Life Sciences Tools & Services
IPO
May 15, 1998

ICON PLC, a leading global provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries, has carved a niche for itself in the critical world of clinical research. Founded in 1990 and headquartered in Dublin, Ireland, ICON PLC combines innovative technologies with deep industry expertise to assist clients at every stage of their product development journey. As the demand for faster and more efficient drug development grows,...

[ Read More ]

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about ICON PLC

Provide an overview of the primary business activities
of ICON PLC.

What unique competitive advantages
does ICON PLC hold over its rivals?

What risks and challenges
does ICON PLC face in the near future?

Summarize the latest earnings call
of ICON PLC.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ICON PLC.

Provide P/S
for ICON PLC.

Provide P/E
for ICON PLC.

Provide P/OCF
for ICON PLC.

Provide P/FCFE
for ICON PLC.

Provide P/B
for ICON PLC.

Provide EV/S
for ICON PLC.

Provide EV/GP
for ICON PLC.

Provide EV/EBITDA
for ICON PLC.

Provide EV/EBIT
for ICON PLC.

Provide EV/OCF
for ICON PLC.

Provide EV/FCFF
for ICON PLC.

Provide EV/IC
for ICON PLC.

Show me price targets
for ICON PLC made by professional analysts.

What are the Revenue projections
for ICON PLC?

How accurate were the past Revenue estimates
for ICON PLC?

What are the Net Income projections
for ICON PLC?

How accurate were the past Net Income estimates
for ICON PLC?

What are the EPS projections
for ICON PLC?

How accurate were the past EPS estimates
for ICON PLC?

What are the EBIT projections
for ICON PLC?

How accurate were the past EBIT estimates
for ICON PLC?

Compare the revenue forecasts
for ICON PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ICON PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ICON PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of ICON PLC compared to its peers.

Compare the P/E ratios
of ICON PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing ICON PLC with its peers.

Analyze the financial leverage
of ICON PLC compared to its main competitors.

Show all profitability ratios
for ICON PLC.

Provide ROE
for ICON PLC.

Provide ROA
for ICON PLC.

Provide ROIC
for ICON PLC.

Provide ROCE
for ICON PLC.

Provide Gross Margin
for ICON PLC.

Provide Operating Margin
for ICON PLC.

Provide Net Margin
for ICON PLC.

Provide FCF Margin
for ICON PLC.

Show all solvency ratios
for ICON PLC.

Provide D/E Ratio
for ICON PLC.

Provide D/A Ratio
for ICON PLC.

Provide Interest Coverage Ratio
for ICON PLC.

Provide Altman Z-Score Ratio
for ICON PLC.

Provide Quick Ratio
for ICON PLC.

Provide Current Ratio
for ICON PLC.

Provide Cash Ratio
for ICON PLC.

What is the historical Revenue growth
over the last 5 years for ICON PLC?

What is the historical Net Income growth
over the last 5 years for ICON PLC?

What is the current Free Cash Flow
of ICON PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for ICON PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ICON PLC

Current Assets 3.8B
Cash & Short-Term Investments 695.5m
Receivables 2.9B
Other Current Assets 140.5m
Non-Current Assets 13.4B
Long-Term Investments 53.7m
PP&E 522.7m
Intangibles 12.7B
Other Non-Current Assets 164.4m
Current Liabilities 2.8B
Accounts Payable 106.2m
Accrued Liabilities 38.5m
Other Current Liabilities 2.7B
Non-Current Liabilities 4.6B
Long-Term Debt 3.4B
Other Non-Current Liabilities 1.2B
Efficiency

Earnings Waterfall
ICON PLC

Revenue
8.3B USD
Cost of Revenue
-5.8B USD
Gross Profit
2.5B USD
Operating Expenses
-1.3B USD
Operating Income
1.1B USD
Other Expenses
-395.6m USD
Net Income
747.9m USD

Free Cash Flow Analysis
ICON PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ICLR Profitability Score
Profitability Due Diligence

ICON PLC's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Free Cash Flow
Positive Gross Profit
ROE is Increasing
53/100
Profitability
Score

ICON PLC's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

ICLR Solvency Score
Solvency Due Diligence

ICON PLC's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
55/100
Solvency
Score

ICON PLC's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ICLR Price Targets Summary
ICON PLC

Wall Street analysts forecast ICLR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ICLR is 291.06 USD with a low forecast of 227.25 USD and a high forecast of 393.75 USD.

Lowest
Price Target
227.25 USD
7% Upside
Average
Price Target
291.06 USD
37% Upside
Highest
Price Target
393.75 USD
86% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ICLR?

Click here to dive deeper.

Dividends

ICON PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for ICLR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

ICLR News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one ICLR stock?

The intrinsic value of one ICLR stock under the Base Case scenario is 307.98 USD.

Is ICLR stock undervalued or overvalued?

Compared to the current market price of 212.15 USD, ICON PLC is Undervalued by 31%.

Back to Top